Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NHO - Matsumoto Medical Center
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients who received chemotherapy (FOLFOX) including bevacizumab. The patients had an associated reduction in tumor vascularity as estimated by ultrasonography and consequently underwent surgical resection of the metastatic liver tumors for curative purposes.
